Dr. Rebecca J. Zadroga, MD

Dr. Zadroga practices at Hennepin County Medical Center in Minneapolis, Minnesota, part of Hennepin County.

Dr. Zadroga's NPI, 1023178746, was assigned on December 11, 2006. Dr. Zadroga holds Minnesota license 48233.

Dr. Zadroga's primary practice is Hennepin County Medical Center, at 701 Park Avenue, Minneapolis, MN 55415 in Hennepin County. The practice phone is (612) 873-3000.

Dr. Zadroga's primary practice is Hennepin County Medical Center in Minneapolis, Minnesota, part of Hennepin County. Dr. Zadroga is also affiliated with Lake Granbury Medical Center. The medical group on file is Hennepin Healthcare. Dmand AI also links Dr. Zadroga to 2 more medical groups, each named with a free account. Dr. Zadroga's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zadroga practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Zadroga's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Zadroga is board certified in infectious disease by the American Board of Internal Medicine. Dr. Zadroga is licensed in Minnesota.

CMS data shows 33 Medicare services from Dr. Zadroga across 2 procedure codes in 2024, for 53 Medicare patients. Medicare paid $3,246 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 53 Medicare patients who saw Dr. Zadroga in 2024. The largest group is under 65, with 32 patients. 75% of them have high blood pressure, and 74% have chronic kidney disease. 72% are also on Medicaid. Their average risk score is 4.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zadroga's median patient age at 54, with 51% women.

In 2024, Dr. Zadroga wrote 255 Medicare Part D claims for 59 patients. 84% of them were for generic drugs. CMS names the drug for 52 of them, across 4 drugs with 11 or more claims each, at $1,932 in total drug cost. In 2023, CMS named 386 claims across 23 drugs.

Dr. Zadroga accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zadroga as offering telehealth.

Dmand AI links 4 papers to Dr. Zadroga, published from 2012 to 2022. 2012 was the busiest year, with 2. The most frequent topics are Anti-Bacterial Agents, Bacteremia and Bacteria. Dr. Zadroga has published most often in Clin Infect Dis. Dr. Zadroga's most frequent co-authors are Anne Semmer Abel, MD, Abdhish Raman Bhavsar, MD and Lisa Carlson, MD.

CMS Open Payments shows 10 general payments to Dr. Zadroga from 6 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 73% of the total. Insmed, Inc. paid the most, $49.